Merck has collaborated with nonprofit research organization IAVI to develop a COVID-19 vaccine, which would use the recombinant vesicular stomatitis virus technology applied in its Ebola Zaire virus vaccine. Yourway provides temperature-controlled solutions to preserve even the most fragile drug substances during shipment.